|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
|
US3726268A
(en)
|
1971-05-03 |
1973-04-10 |
R Stansell |
Cooking apparatus
|
|
BE786675A
(fr)
|
1971-08-02 |
1973-01-25 |
Airco Inc |
Separation d'oxydes d'alkyle halogenes par distillation azeotropique.
|
|
US3846332A
(en)
|
1971-08-02 |
1974-11-05 |
Airco Inc |
Azeotropes of 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether with acetone, methyl ethylketone and tetrahydrofuran
|
|
US3897502A
(en)
|
1971-10-22 |
1975-07-29 |
Airco Inc |
Process for making fluorinated ethers
|
|
JPS523342B2
(enExample)
|
1972-01-26 |
1977-01-27 |
|
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
|
US4818542A
(en)
|
1983-11-14 |
1989-04-04 |
The University Of Kentucky Research Foundation |
Porous microspheres for drug delivery and methods for making same
|
|
US4584894A
(en)
|
1984-02-29 |
1986-04-29 |
Borg-Warner Corporation |
Transmission anti-clash and anti-rattle brake
|
|
US5417986A
(en)
|
1984-03-16 |
1995-05-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
|
ATE61935T1
(de)
|
1985-02-07 |
1991-04-15 |
Takeda Chemical Industries Ltd |
Verfahren zur herstellung von mikrokapseln.
|
|
JP2551756B2
(ja)
|
1985-05-07 |
1996-11-06 |
武田薬品工業株式会社 |
ポリオキシカルボン酸エステルおよびその製造法
|
|
US5102872A
(en)
|
1985-09-20 |
1992-04-07 |
Cetus Corporation |
Controlled-release formulations of interleukin-2
|
|
GB8601100D0
(en)
|
1986-01-17 |
1986-02-19 |
Cosmas Damian Ltd |
Drug delivery system
|
|
EP0248531A3
(en)
|
1986-05-02 |
1988-09-28 |
Southern Research Institute |
Encapsulated nucleic acids
|
|
ES2053549T3
(es)
|
1986-08-11 |
1994-08-01 |
Innovata Biomed Ltd |
Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion.
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US4762856A
(en)
|
1987-02-02 |
1988-08-09 |
Boc, Inc. |
Anesthetic composition and method of using the same
|
|
US4861627A
(en)
|
1987-05-01 |
1989-08-29 |
Massachusetts Institute Of Technology |
Preparation of multiwall polymeric microcapsules
|
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
US5015781A
(en)
|
1988-05-06 |
1991-05-14 |
Boc, Inc. |
Anesthetic compound and method of preparing
|
|
US4874901A
(en)
|
1988-05-06 |
1989-10-17 |
Boc, Inc. |
Process for the production of polyfluorinated ethers
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
US4972040A
(en)
|
1988-07-18 |
1990-11-20 |
Boc, Inc. |
Process for the preparation of CHF2 OCHFCF3
|
|
US4855511A
(en)
|
1988-07-18 |
1989-08-08 |
Boc, Inc. |
Process for preparing CHF2 OCHFCF3 and CHF2 OCHClCF3 and novel intermediate compounds employed therein
|
|
USRE39497E1
(en)
|
1989-02-16 |
2007-02-27 |
Nektar Therapeutics |
Storage of materials
|
|
GB8903593D0
(en)
|
1989-02-16 |
1989-04-05 |
Pafra Ltd |
Storage of materials
|
|
US5026924A
(en)
|
1989-03-14 |
1991-06-25 |
Anaquest, Inc. |
Process for production of 1,2,2,2-tetrafluoroethyl difluoromethyl ether
|
|
WO1990013361A1
(en)
|
1989-05-04 |
1990-11-15 |
Southern Research Institute |
Improved encapsulation process and products therefrom
|
|
MY107937A
(en)
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
|
ES2185615T3
(es)
|
1990-05-16 |
2003-05-01 |
Southern Res Inst |
Uso y liberacion controlada de las microcapsulas para estimular el crecimiento de la fibra nerviosa.
|
|
JPH0436233A
(ja)
*
|
1990-05-29 |
1992-02-06 |
Biomaterial Universe Kk |
生理活性物質含有生体内分解吸収性の徐放性製剤
|
|
GB9016885D0
(en)
|
1990-08-01 |
1990-09-12 |
Scras |
Sustained release pharmaceutical compositions
|
|
US5149543A
(en)
|
1990-10-05 |
1992-09-22 |
Massachusetts Institute Of Technology |
Ionically cross-linked polymeric microcapsules
|
|
GB9023370D0
(en)
|
1990-10-26 |
1990-12-05 |
Rhone Poulenc Chemicals |
Synthesis of fluorinated substituted ethanes
|
|
IT1243390B
(it)
*
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
|
WO1992014449A1
(en)
|
1991-02-20 |
1992-09-03 |
Nova Pharmaceutical Corporation |
Controlled release microparticulate delivery system for proteins
|
|
US5330768A
(en)
|
1991-07-05 |
1994-07-19 |
Massachusetts Institute Of Technology |
Controlled drug delivery using polymer/pluronic blends
|
|
US6063910A
(en)
|
1991-11-14 |
2000-05-16 |
The Trustees Of Princeton University |
Preparation of protein microparticles by supercritical fluid precipitation
|
|
US5283372A
(en)
|
1991-12-04 |
1994-02-01 |
Anaquest, Inc. |
Preparation of purified optical isomers of desflurane
|
|
US5525519A
(en)
|
1992-01-07 |
1996-06-11 |
Middlesex Sciences, Inc. |
Method for isolating biomolecules from a biological sample with linear polymers
|
|
US5173454A
(en)
|
1992-01-09 |
1992-12-22 |
Corning Incorporated |
Nanocrystalline materials
|
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
DE4211169C1
(enExample)
|
1992-03-31 |
1993-06-03 |
Klaus Kretzschmar |
|
|
JP2651320B2
(ja)
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
|
US5205914A
(en)
|
1992-08-14 |
1993-04-27 |
Anaquest, Inc. |
Synthesis of desflurane
|
|
JP3277342B2
(ja)
|
1992-09-02 |
2002-04-22 |
武田薬品工業株式会社 |
徐放性マイクロカプセルの製造法
|
|
EP0595030A3
(en)
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Multi-core microspheres with delayed drug delivery and process for their manufacture.
|
|
JPH08503950A
(ja)
|
1992-12-02 |
1996-04-30 |
アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド |
徐放性成長ホルモン含有マイクロスフェア
|
|
WO1994018947A1
(en)
*
|
1993-02-16 |
1994-09-01 |
Sharifa Karali |
High purity protamine-dna complex and use of same
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US6090925A
(en)
*
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
ES2113094T3
(es)
|
1993-03-09 |
1998-04-16 |
Epic Therapeutics Inc |
Las microparticulas macromoleculares y metodos de obtencion.
|
|
US5994314A
(en)
|
1993-04-07 |
1999-11-30 |
Inhale Therapeutic Systems, Inc. |
Compositions and methods for nucleic acid delivery to the lung
|
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
JP4619457B2
(ja)
|
1993-11-18 |
2011-01-26 |
シルテックス、メディカル、リミテッド |
徐放性製剤
|
|
ATE212830T1
(de)
|
1993-11-19 |
2002-02-15 |
Alkermes Inc |
Herstellung biologisch abbaubarer, einen biologisch aktiven stoff enthaltender, mikropartikel
|
|
US5650173A
(en)
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
|
US5858973A
(en)
|
1994-02-23 |
1999-01-12 |
The General Hospital Corporation |
Transcription factor and uses therefor
|
|
ATE252373T1
(de)
|
1994-08-04 |
2003-11-15 |
Elan Drug Delivery Ltd |
Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
US5542920A
(en)
|
1994-09-12 |
1996-08-06 |
Delab |
Needle-less parenteral introduction device
|
|
US6387399B1
(en)
|
1994-12-02 |
2002-05-14 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Microencapsulated bioactive agents and method of making
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
|
SE505146C2
(sv)
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
|
US5665428A
(en)
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
|
US5958769A
(en)
|
1996-01-18 |
1999-09-28 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for mediating cell cycle progression
|
|
GB9607035D0
(en)
|
1996-04-03 |
1996-06-05 |
Andaris Ltd |
Spray-dried microparticles as therapeutic vehicles
|
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
|
AU3739697A
(en)
|
1996-07-09 |
1998-02-02 |
Johns Hopkins University, The |
Gene delivery system
|
|
US6395302B1
(en)
|
1996-11-19 |
2002-05-28 |
Octoplus B.V. |
Method for the preparation of microspheres which contain colloidal systems
|
|
US6077833A
(en)
|
1996-12-31 |
2000-06-20 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
|
US6319906B1
(en)
|
1996-12-31 |
2001-11-20 |
Isis Pharmaceuticals |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
|
AU7134898A
(en)
|
1997-04-17 |
1998-11-11 |
Amgen, Inc. |
Biodegradable microparticles for the sustained delivery of therapeutic drugs
|
|
DK1017365T3
(da)
*
|
1997-06-23 |
2004-03-29 |
Alza Corp |
Liposomomsluttet polynukleotidsammensætning og fremgangsmåde
|
|
US6153211A
(en)
|
1997-07-18 |
2000-11-28 |
Infimed, Inc. |
Biodegradable macromers for the controlled release of biologically active substances
|
|
US6042792A
(en)
|
1997-09-18 |
2000-03-28 |
International Flavors & Fragrances Inc. |
Apparatus for preparing a solid phase microparticulate composition
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
|
CA2318493A1
(en)
*
|
1998-01-16 |
1999-07-22 |
The Johns Hopkins University |
Oral delivery of nucleic acid vaccines by particulate complexes
|
|
US20040186071A1
(en)
|
1998-04-13 |
2004-09-23 |
Bennett C. Frank |
Antisense modulation of CD40 expression
|
|
US6395253B2
(en)
*
|
1998-04-23 |
2002-05-28 |
The Regents Of The University Of Michigan |
Microspheres containing condensed polyanionic bioactive agents and methods for their production
|
|
US6197584B1
(en)
|
1998-05-01 |
2001-03-06 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of CD40 expression
|
|
WO2000009086A2
(en)
|
1998-08-14 |
2000-02-24 |
Valentis, Inc. |
Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
|
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
|
DE60003151T2
(de)
|
1999-01-13 |
2004-04-08 |
Johns Hopkins University School Of Medicine |
Genetische immunisierung mit gleichzeitiger verabreichung von nukleinsäuren und zytokinen
|
|
GB9904627D0
(en)
*
|
1999-03-02 |
1999-04-21 |
Danbiosyst Uk |
Polymer compositions for polynucleotide delivery
|
|
US6630169B1
(en)
|
1999-03-31 |
2003-10-07 |
Nektar Therapeutics |
Particulate delivery systems and methods of use
|
|
AU3957400A
(en)
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
|
EP1046651A1
(en)
*
|
1999-04-19 |
2000-10-25 |
Koninklijke Universiteit Nijmegen |
Composition and method for modulating dendritic cell-T interaction
|
|
CA2373016A1
(en)
|
1999-05-04 |
2000-11-09 |
Genethor Gmbh |
Method for diminishing specific immune reactions
|
|
EP1060741B1
(en)
|
1999-06-14 |
2003-09-03 |
Baxter International Inc. |
Sustained release microspheres
|
|
WO2001001964A2
(en)
|
1999-06-23 |
2001-01-11 |
Sedum Laboratories, Inc. |
Ionically formulated biomolecule microcarriers
|
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
US7129222B2
(en)
*
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
|
FR2809309B1
(fr)
|
2000-05-23 |
2004-06-11 |
Mainelab |
Microspheres a liberation prolongee pour administration injectable
|
|
CN1437482A
(zh)
|
2000-05-26 |
2003-08-20 |
西福根有限公司 |
用于治疗变态反应的重组的或纯化的多克隆抗体
|
|
US6849259B2
(en)
|
2000-06-16 |
2005-02-01 |
Symphogen A/S |
Polyclonal antibody composition for treating allergy
|
|
KR100392501B1
(ko)
|
2000-06-28 |
2003-07-22 |
동국제약 주식회사 |
다중 에멀젼법에 의한 서방출성 미립구의 제조방법
|
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
|
DE60139944D1
(de)
|
2000-10-12 |
2009-10-29 |
Genentech Inc |
Niederviskose konzentrierte proteinformulierungen
|
|
SE518007C2
(sv)
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Förfarande för framställning av mikropartiklar
|
|
EP1801123A3
(en)
|
2000-12-28 |
2007-11-21 |
Altus Pharmaceuticals Inc. |
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
|
EP1345968A2
(en)
|
2000-12-28 |
2003-09-24 |
Altus Biologics Inc. |
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
|
US6896905B2
(en)
|
2001-02-15 |
2005-05-24 |
Rohm And Haas Company |
Porous particles, their aqueous dispersions, and method of preparation
|
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
|
JP2005500304A
(ja)
|
2001-06-21 |
2005-01-06 |
アルタス バイオロジックス インコーポレイテッド |
球状タンパク質粒子およびそれらの作製方法および使用方法
|
|
US20080026068A1
(en)
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
|
US20030064033A1
(en)
|
2001-08-16 |
2003-04-03 |
Brown Larry R. |
Propellant-based microparticle formulations
|
|
GB0207440D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Ppl Therapeutics Scotland Ltd |
Tolerogenic antigen-presenting cells
|
|
WO2005123131A2
(en)
|
2004-06-14 |
2005-12-29 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
|
US20030224055A1
(en)
|
2002-05-28 |
2003-12-04 |
Lewis David L. |
Compositions and processes for inhibiting gene expression using polynucleotides
|
|
US6900998B2
(en)
|
2002-05-31 |
2005-05-31 |
Midwest Research Institute |
Variable-speed wind power system with improved energy capture via multilevel conversion
|
|
AU2003251592A1
(en)
|
2002-06-21 |
2004-01-06 |
Biogen Idec Inc. |
Buffered formulations for concentrating antibodies and methods of use thereof
|
|
US20040014698A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Gonzalo Hortelano |
Oral administration of therapeutic agent coupled to transporting agent
|
|
KR20050088175A
(ko)
|
2002-12-17 |
2005-09-02 |
메드이뮨 백신즈 인코포레이티드 |
생물활성 물질의 고압 분무 건조
|
|
US20060002862A1
(en)
|
2002-12-17 |
2006-01-05 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
|
WO2004060343A1
(en)
|
2002-12-31 |
2004-07-22 |
Nektar Therapeutics |
Antibody-containing particles and compositions
|
|
PT1610820E
(pt)
|
2003-04-04 |
2010-12-16 |
Novartis Ag |
Formulações de elevada concentração de anticorpos e proteínas
|
|
US20050158303A1
(en)
|
2003-04-04 |
2005-07-21 |
Genentech, Inc. |
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
|
ES2216707B1
(es)
|
2003-04-08 |
2005-12-16 |
Josep Maria Aran Perramon |
Secuencia oligoribonucleotidica homologa a una region del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes.
|
|
US7723311B2
(en)
|
2003-06-18 |
2010-05-25 |
Nanobiomagnetics, Inc. |
Delivery of bioactive substances to target cells
|
|
JP5087274B2
(ja)
|
2003-06-30 |
2012-12-05 |
ドマンティス リミテッド |
ポリペプチド
|
|
US7066023B2
(en)
|
2003-07-14 |
2006-06-27 |
Environmental Security Corporation |
Distributed sensor array for fluid contaminant monitoring
|
|
US20050142205A1
(en)
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
|
US8075919B2
(en)
|
2003-07-18 |
2011-12-13 |
Baxter International Inc. |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
|
DE10355904A1
(de)
|
2003-11-29 |
2005-06-30 |
Merck Patent Gmbh |
Feste Formen von anti-EGFR-Antikörpern
|
|
US20070161586A1
(en)
*
|
2004-01-16 |
2007-07-12 |
Takeda Pharmaceutical Company Limited |
Drug for preventing and treating atherosclerosis
|
|
WO2005072527A2
(en)
|
2004-01-23 |
2005-08-11 |
Avi Biopharma, Inc. |
Antisense oligomers and methods for inducing immune tolerance and immunosuppression
|
|
EP1713502A1
(de)
|
2004-02-12 |
2006-10-25 |
MERCK PATENT GmbH |
Hochkonzentrierte, flüssige formulierungen von anti-egfr-antikörpern
|
|
US7884085B2
(en)
*
|
2004-05-12 |
2011-02-08 |
Baxter International Inc. |
Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
|
|
EP1765294B1
(en)
*
|
2004-05-12 |
2008-09-24 |
Baxter International Inc. |
Nucleic acid microspheres, production and delivery thereof
|
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
|
WO2006072527A1
(de)
|
2005-01-05 |
2006-07-13 |
Siemens Aktiengesellschaft |
Head-up-display für ein kraftfahrzeug
|
|
JP4595112B2
(ja)
|
2005-02-14 |
2010-12-08 |
独立行政法人産業技術総合研究所 |
タンパク質の高効率分離または濃縮方法
|
|
ES2407468T3
(es)
|
2005-04-18 |
2013-06-12 |
Yeda Research And Development Company Limited |
Formulaciones de anticuerpos anti-hepatitis B (HBV) estabilizadas
|
|
RU2303833C2
(ru)
|
2005-07-26 |
2007-07-27 |
Самсунг Электро-Меканикс Ко., Лтд. |
Осветительное устройство
|
|
JP5405122B2
(ja)
|
2005-12-21 |
2014-02-05 |
ワイス・エルエルシー |
低粘度のタンパク質製剤およびその用途
|